Research Administration Operations Update

Tuesday, May 18, 2021 02:00pm, EDT

Featured Funding Opportunities

Explore a wide range of curated internal and external funding opportunities to help advance your research and scholarly activities.

Filter

Discipline
Funding Source
Funding Type

About 125 results

  • Funding Agency Alex’s Lemonade Stand Foundation
    Funding Source Foundation
    Amount 800000
    External Deadline 06/18/2021
    Website Sponsor Info

    The 'A' Award is designed for the early independent career scientist who wants to establish a career in pediatric oncology research. The ideal candidate has an original project, can demonstrate outstanding career development support from the institution, and has a strong future commitment to pediatric cancer investigation. These awards are open to MD, MD/PhD and PhD applicants who are within 5 years of their first faculty appointment as an Assistant Professor. 

  • Funding Agency Smith Richardson Foundation: 
    Funding Source Foundation
    Amount $60,000
    External Deadline 06/18/2021
    Website Sponsor Info

    The Smith Richardson Foundation sponsors an annual Strategy and Policy Fellows grant competition to support young scholars and policy thinkers on American foreign policy, international relations, international security, military policy, and diplomatic and military history.  The purpose of the program is to strengthen the U.S. community of scholars and researchers conducting policy analysis in these fields.

  • Funding Agency Area of Focus: Proposals should focus on antimicrobial therapy consumption, use patterns, and stewardship efforts in the outpatient setting, in low-income countries or under-resourced settings in middle-income countries. Antimicrobial stewardship programs confined to the clinical healthcare setting are not enough to effectively prevent the development and spread of antimicrobial resistance. Patient use behaviors, spurred by access to antimicrobial therapies in settings outside of traditional hospitals, are a neglected area that will benefit from novel antimicrobial stewardship programs. Award: Proposals from eligible organizations requesting up to $100,000 will be considered. The total available budget related to this RFP is $1,000,000
    Funding Source Corporate
    Amount Requests up to $100,000 will be considered
    External Deadline 06/18/2021
    Website Sponsor Site

    Area of Focus: Proposals should focus on antimicrobial therapy consumption, use patterns, and stewardship efforts in the outpatient setting, in low-income countries or under-resourced settings in middle-income countries. Antimicrobial stewardship programs confined to the clinical healthcare setting are not enough to effectively prevent the development and spread of antimicrobial resistance. Patient use behaviors, spurred by access to antimicrobial therapies in settings outside of traditional hospitals, are a neglected area that will benefit from novel antimicrobial stewardship programs.

    Award: Proposals from eligible organizations requesting up to $100,000 will be considered. The total available budget related to this RFP is $1,000,000

    For further information: frontdoor@rutgers.edu

  • Funding Agency Pfizer
    Funding Source Corporate
    Amount A total of $1.5 Million is available to fund selected projects.
    External Deadline 06/21/2021
    Website Sponsor Site

    Area of Interest: The overall aim is to develop innovative investigations to help determine the role of talazoparib and foster the development of PARPi in prostate cancer. Proposals should focus on clinical development of talazoparib alone or in combinations, understanding the biologic mechanisms of talazoparib, or defining optimal patient factors and other predictive biomarkers of clinical benefit. Both clinical trials with correlative endpoints and basic research proposals are encouraged.

    The following areas of pre-clinical research are encouraged:

    1. Mechanisms of action of talazoparib
    2. Role of PARP trapping in response and resistance
    3. Predictors of response and resistance to talazoparib
    4. Models of resistance
    5. Novel combinations with talazoparib

    The following areas of clinical and translational research are encouraged:

    1. Clinical trials to understand biomarkers of response to talazoparib
    2. Clinical trials to understand and overcome resistance to talazoparib
    3. Role of talazoparib in other prostate cancer disease states beyond metastatic CRPC
    4. Novel combinations with talazoparib
    5. Translational research using existing tissue specimens and/or databases to better understand the role of talazoparib in prostate cancer treatment

    Specific Exclusions from this RFP include:

    1. Studies that do not include talazoparib
    2. Studies in tumor types other than prostate cancer
    3. Combinations with chemotherapy or immunotherapy
    4. Clinical trials that compare talazoparib to chemotherapy
    5. Pediatric studies

    Award: A total of $1.5 Million is available to fund selected projects. It is anticipated that 3-5 projects will be awarded funding but the final number will depend on the quality of the projects and is at the discretion of the review panel. The maximum indirect (overhead) rate is 28% and must be included in the total grant amount requested.

    For further information: frontdoor@rutgers.edu

  • Funding Agency Semiconductor Research Corp.
    Funding Source Corporate
    Amount $100k
    External Deadline 06/22/2021
    Website Sponsor Site

    Area of Interest: The research needs are outlined in the Computer-Aided Design and Test Research Program needs document. Researchers should carefully review this document.

    Award: It is the intention of the members for selected projects to be reviewed and renewed annually, but we anticipate that a project will have a lifetime of 3 years to support the completion of a doctoral dissertation. SRC projects typically involve 1-2 graduate students. SRC expects to support each project up to $100K (USD) per year.

    For further information: frontdoor@rutgers.edu

  • Funding Agency Doris Duke Charitable Foundation
    Funding Source Foundation
    Amount $500,000
    External Deadline 06/22/2021
    Website Sponsor Info

    The purpose of the Fund to Retain Clinical Scientists, is to provide supplemental, flexible funds to early-career physician scientists working on clinical research projects and facing extraprofessional demands of caregiving.   The COVID-19 Fund to Retain Clinical Scientists grant opportunity is available for U.S. medical schools that are evolving to strengthen policies, practices and processes to support the research productivity and retention of early-career faculty with family caregiving responsibilities.  

  • Funding Agency Lever For Change, Additional Ventures, ICONIQ
    Funding Source Foundation
    Amount $12,000,000 available
    External Deadline 06/22/2021
    Website Sponsor Info

    Stronger Democracy Award seeks bold solutions that will drive structural reform to help our government fully and effectively represent its citizens. Proposed projects will address systemic barriers and advance structural reforms in one of three areas: voting and elections, policymaking, and/or civic engagement. The objective of the Award is to incentivize our government to be more responsive to the broader electorate and ensure that it is staffed with high quality, high-functioning institutions and people.

    Registration Deadline:  June 22, 2021

    Application Deadline:  July 22, 2021

  • Funding Agency Seimconductor Research Corporation
    Funding Source Foundation
    Amount $300,000
    External Deadline 06/22/2021
    Website Sponsor Info

    The Computer-Aided Design and Test (CADT) research program at the Semiconductor Research Corporation (SRC) is soliciting university proposals to address challenges facing the industry. These challenges have been identified by experts in SRC member companies and they have indicated that machine learning techniques applied to the challenges are of keen interest but not necessarily required in successful submissions. Researchers are encouraged to utilize industry standard tools as a basis or reference point, and to specify clearly not only how their research goes beyond the industry state-of-the-art, but also how they would put their results into practice in an industrial setting alongside existing methodologies and tools.

  • Funding Agency Pfizer
    Funding Source Corporate
    Amount Requests up to $150K will be considered.
    External Deadline 06/23/2021
    Website Sponsor Site

    Area of Interest: Projects that will be considered for Pfizer support will be Quality Improvement initiatives that analyze and improve biomarker testing practices in NSCLC. For patients diagnosed with metastatic NSCLC, sub-optimal biomarker testing practices continue to exist. A high percentage of patients are initiated on therapy before the care team receives the results of a comprehensive biomarker testing panel. For some patients, standardized biomarker tests are not performed at all.1 Grant support is available to cancer centers or hospitals interested in forming multi-disciplinary teams to analyze their own testing practices and identify areas of improvement using Quality Improvement (QI) methodology such as root cause analysis, Plan Do Study Act (PDSA) cycles etc.

    Award: Individual projects requesting up to $150K will be considered. The estimated total available budget related to this RFP is $450,000

    For further information: frontdoor@rutgers.edu

  • Funding Agency National Institutes of Health (NIH)
    Funding Source Government
    Amount Not limited
    Internal Submission Deadline 04/29/2021
    External Deadline 06/24/2021
    # of Submissions Allowed 1 per DUNS
    Website Sponsor Site

    The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research

    To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

    • Courses for Skills Development
    • Research Experiences

    for undergraduate freshmen and sophomores from diverse backgrounds, including those from groups underrepresented in bioengineering or STEM fields relevant to bioengineering, such as engineering or the physical/computational sciences, which play key roles in biomedical technologies and innovation. The ESTEEMED program is intended to expose students to bioengineering research early in their college careers and interest them in potentially pursuing advanced studies in bioengineering or a related field. It will prepare students to join, in their junior and senior years, an honors program, supported by federal or institutional funds, that promotes STEM and entrance into a Ph.D. program. The ultimate goal is for the participants to pursue a Ph.D. or M.D./Ph.D. degree and a subsequent research career integrating engineering and the physical sciences with medicine and biology in academia or industry.

    This is a limited submission opportunity. Interested faculty from New Brunswick, Newark, and Camden should apply on InfoReady. RBHS faculty should reach out to their school for how to apply.

    For assistance, contact Research Development